On Thursday, Nov. 8, Endo ENDP will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Earnings and Revenue
Endo EPS is expected to be around 59 cents, according to sell-side analysts. Sales will likely be near $696.31 million.
In the same quarter last year, Endo reported earnings per share of 91 cents on sales of $786.88 million. The Wall Street estimate would represent a 35.16 percent decline in the company's earnings. Sales would be down 11.51 percent from the year-ago period. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
| EPS Estimate | 0.54 | 0.54 | 0.61 | 0.67 |
| EPS Actual | 0.76 | 0.67 | 0.77 | 0.91 |
Stock Performance
Over the last 52-week period, shares are up 171.2 percent. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release. Analyst estimates are adjusted lower for EPS and revenues over the past 90 days. The average rating by analysts on Endo stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.
Conference Call
Endo's Q3 conference call is scheduled to begin at 8:00 a.m. ET and can be accessed here: https://edge.media-server.com/m6/p/wee9oweg
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
